<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

Patients Who Smoke In Treatment Do Worse Than Those Who Quit

Dendritic Cell Vaccine May Boost Median Survival

Decline In Breast Cancer May Be Related to Drop In HT

Triple-Negative Breast Cancer Increases With Number of Births

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

Clinical Trials Approved By NCI CTEP Last Month

FDA Approves BMS’s Yervoy For Metastatic Melanoma